Abstract PR05: Loss of PRC2 or KMT2D-COMPASS generates two quasi-mesenchymal cell states with distinct metastatic abilities

Yun Zhang(Duke Medical Center), Robert A. Weinberg(Whitehead Institute for Biomedical Research), Nathan A. Lack(Koç University), Mehreen Ali Khan(National Institute Of Blood Disease and Bone Marrow Transplantation), Jordan A. Krall(Casma Therapeutics (United States)), Ferenc Reinhardt(Whitehead Institute for Biomedical Research), Michael Tyler(Georg Speyer Haus), Tamer T. Önder(Koç University), Sunny Das(Whitehead Institute for Biomedical Research), Aviv Regev(Broad Institute), Heather R. Keys(Whitehead Institute for Biomedical Research), Matan Hofree(Broad Institute), Joana Liu Donaher(Whitehead Institute for Biomedical Research), Prathapan Thiru(Whitehead Institute for Biomedical Research), Tugba Bagcı-Önder(Koç University), Molly M. Wilson(Massachusetts Institute of Technology), Arthur W. Lambert(AstraZeneca (South Korea)), Jacqueline A. Lees(Massachusetts Institute of Technology), Xin Li(Third Affiliated Hospital of Southern Medical University), Ozlem Yedier-Bayram(Koç University), Itay Tirosh(Weizmann Institute of Science)
Cancer Research
December 1, 2020
Cited by 0


Related Papers